Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular Diagnostics Signs Distribution Agreements With Gamidor, Durviz

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics announced today that it has signed distribution agreements with Gamidor Diagnostics and Durviz s.l. Parque Tecnológico de Valencia to distribute its next-generation sequencing-based products in Israel, and Spain and Portugal, respectively. 

Gamidor sells diagnostic systems, chemicals, reagents, and services in Israel to hospitals, health management systems, and academic research institutes. Durviz distributes NGS reagents and library preparation systems in Spain and Portugal. 

"By expanding our distribution reach into these markets, we believe the availability of the HTG EdgeSeq system and assays will accelerate the adoption of molecular profiling using NGS," Jean Claude Gerard, HTG's vice president of European commercial operations, said in a statement. "Both Gamidor and Durviz are as passionate as we are at HTG about enabling precision medicine at the local level."

HTG CEO TJ Johnson added that these distribution agreements will serve as models for additional agreements the company may sign with distributors outside the US.